NCT00662233View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients With Sarcoma

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

28

Participants

Timeline

Start Date

October 31, 1991

Primary Completion Date

October 21, 2013

Study Completion Date

October 21, 2013

Conditions

Ovarian CancerSarcoma

Interventions

DRUG

cyclophosphamide

DRUG

doxorubicin hydrochloride

DRUG

etoposide

DRUG

ifosfamide

DRUG

vincristine sulfate

PROCEDURE

adjuvant therapy

PROCEDURE

neoadjuvant therapy

PROCEDURE

therapeutic conventional surgery

RADIATION

brachytherapy

RADIATION

intraoperative radiation therapy

RADIATION

radiation therapy

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER

NCT00662233 - Combination Chemotherapy in Treating Patients With Sarcoma | Biotech Hunter | Biotech Hunter